{"id":"CHEMBL1055","canonicalSmiles":"NS(=O)(=O)c1cc(C2(O)NC(=O)c3ccccc32)ccc1Cl","inchiKey":"JIVPVXMEBJLZRO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORTHALIDONE","yearOfFirstApproval":1960,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Chlorthalidone","Hygroton","Thalitone"],"synonyms":["Chlortalidone","Chlorthalidone","G-33182","NSC-69200"],"crossReferences":{"DailyMed":["chlorthalidone"],"PubChem":["11532862","170464745","26747917"],"Wikipedia":["Chlortalidone"],"drugbank":["DB00310"],"chEBI":["3654"]},"count":16,"approvedIndications":["EFO_0003884","EFO_0000319","EFO_0000537","EFO_0003913"],"linkedTargets":{"rows":["ENSG00000070915"],"count":1},"linkedDiseases":{"rows":["EFO_0003777","HP_0003124","EFO_0001645","EFO_0004278","EFO_0000319","EFO_0000537","EFO_0003913","EFO_0003914","EFO_1001375","EFO_0003144","EFO_0001359","EFO_0003884","EFO_1002032","EFO_0000612","EFO_0003763","EFO_0001360","EFO_0000400"],"count":17},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1960 and has 4 approved and 12 investigational indications."}
{"id":"CHEMBL1082354","canonicalSmiles":"O=C(Nc1ncc([N+](=O)[O-])s1)c1cccs1","inchiKey":"ZLOXYEZYWCTXHU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TENONITROZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tenonitrozole"],"crossReferences":{"PubChem":["144205515","170466466","29216349","50085892"],"Wikipedia":["Tenonitrozole"],"drugbank":["DB13659"]},"childChemblIds":["CHEMBL1388738"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1090777","canonicalSmiles":"O=S(=O)(c1ccc2c(c1)OCCO2)N1CCN(S(=O)(=O)c2c(F)cccc2F)CC1","inchiKey":"SHWNKRPMUBFWKE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1090777","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["57646217","85267861","87225658","99431014"],"drugbank":["DB07692"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL109648","canonicalSmiles":"COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(C)cn2)nc(-c2ccnc(-c3nn[nH]n3)c2)nc1OCCO","inchiKey":"LFWCJABOXHSRGC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLAZOSENTAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Pivlaz"],"synonyms":["ACT-108475","AXV-034343","AXV-343434","Axv-034","Clazosentan","RO-61-1790","Ro 61-1790","VML-588"],"crossReferences":{"drugbank":["DB06677"]},"count":1,"linkedTargets":{"rows":["ENSG00000151617"],"count":1},"linkedDiseases":{"rows":["EFO_0000713"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL1152","canonicalSmiles":"CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C","inchiKey":"LRJOMUJRLNCICJ-JZYPGELDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PREDNISOLONE ACETATE","yearOfFirstApproval":1955,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Econopred","Flo-pred","Meticortelone","Omnipred","Pred forte","Pred fte","Pred mild","Prednisolone acetate","Sterane","Ultracortenol"],"synonyms":["NSC-10966","Prednisolone 21-acetate","Prednisolone Acetate","Prednisolone acetate"],"crossReferences":{"DailyMed":["prednisolone%20acetate"],"PubChem":["144204881","170464632","56422451","855649"],"drugbank":["DB15566"],"chEBI":["8380"]},"count":14,"approvedIndications":["MP_0001845","EFO_0009552","EFO_0007141","HP_0001742","EFO_0005752"],"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["HP_0007957","EFO_0001059","EFO_1000811","MONDO_0003005","EFO_1000997","MONDO_0017634","EFO_1000879","EFO_1000906","EFO_1001157","EFO_0003770","EFO_1001888","EFO_0005773","HP_0001742","HP_0011868","HP_0004798","MP_0001845","EFO_1001231","EFO_0000678","HP_0003419","EFO_0007141","EFO_0009552","EFO_0005752"],"count":22},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1955 and has 5 approved and 9 investigational indications."}
{"id":"CHEMBL1161221","canonicalSmiles":"O=P(O)(O)C(F)(F)c1ccc2ccc(C(F)(F)P(=O)(O)O)cc2c1","inchiKey":"VHKBLEYUHBIBNR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1161221","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03154"]},"childChemblIds":["CHEMBL119459"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1164608","canonicalSmiles":"O=C(NC(=O)c1c(F)cccc1F)Nc1ccc(Cl)c(Oc2ncc(C(F)(F)F)cc2Cl)c1","inchiKey":"YOWNVPAUWYHLQX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUAZURON","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fluazuron"],"crossReferences":{"PubChem":["144205899","225144272","29217963"],"drugbank":["DB15583"],"chEBI":["39374"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1197051","canonicalSmiles":"CC(COc1ccccc1)NC(C)C(O)c1ccc(O)cc1","inchiKey":"BMUKKTUHUDJSNZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISOXSUPRINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Isoxsuprine"],"crossReferences":{"Wikipedia":["Isoxsuprine"]},"childChemblIds":["CHEMBL559180"],"linkedTargets":{"rows":["ENSG00000169252","ENSG00000171873","ENSG00000170214","ENSG00000120907"],"count":4},"linkedDiseases":{"rows":["EFO_0003885"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL11978","canonicalSmiles":"CNC(=O)c1cccnc1","inchiKey":"ZYVXHFWBYUDDBM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NICOTINYL METHYLAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nicotinyl Methylamide","Nicotinyl methylamide"],"crossReferences":{"drugbank":["DB08840"],"chEBI":["64399"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1198","canonicalSmiles":"CCCCOc1ccc(OCCCN2CCOCC2)cc1","inchiKey":"DQKXQSGTHWVTAD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRAMOXINE","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Pramocaine","Pramoxine"],"crossReferences":{"DailyMed":["pramoxine%20hydrochloride"],"PubChem":["11112434"],"Wikipedia":["Pramocaine"],"drugbank":["DB09345"],"chEBI":["8357"]},"childChemblIds":["CHEMBL1201171"],"count":2,"approvedIndications":["HP_0000989","EFO_0009552"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1976 and is indicated for hemorrhoid and pruritus."}
{"id":"CHEMBL1200517","canonicalSmiles":"CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21.CS(=O)(=O)O","inchiKey":"ADYPXRFPBQGGAH-UMYZUSPBSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DIHYDROERGOTAMINE MESYLATE","yearOfFirstApproval":1946,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1732","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["D.h.e. 45","Diergo","Dihydergot","Dihydroergotamine mesylate","Tonopan"],"synonyms":["DHE-45","Dihydroergotamine Methanesulfonate","Dihydroergotamine mesilate","Dihydroergotamine mesylate","Dihydroergotamine methanesulfonate"],"crossReferences":{"DailyMed":["dihydroergotamine%20mesylate"],"PubChem":["50106120"],"chEBI":["59756"]},"count":1,"approvedIndications":["EFO_0003821"],"linkedTargets":{"rows":["ENSG00000179546"],"count":1},"linkedDiseases":{"rows":["EFO_0003821"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1946 and is indicated for migraine disorder. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200574","canonicalSmiles":"[Cl-].[Na+]","inchiKey":"FAPWRFPIFSIZLT-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM CHLORIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aqsia (balanced salt soln)","Askina","Askina jet","Balanced salt","Broncho saline","Bss (balanced salt soln)","Flowfusor","Fresenius","Hypromellose in ringers soln","Iocare (balanced salt soln)","Irriclens","Isot saline","Labmist","Lockes","Macoperf","Miniversol","Muro 128","Nine lives","Normasol","Oft cusi antiedema","Optiflo s","Physiomer","Ringer's","Ringer-locke","S-chlor sf","Salex","Saline","Saline steripoule","Salinex","Slow sod","Sodiclor","Sodium chloride","Sodium chloride 14.6%","Sodium chloride 23.4%","Sterac","Steri-wash","Sterijet","Syrisal","Table Salt","Topiclens","Tubilux","Uriflex-s","Uriflex-sp","Uroclens","Vitaclean"],"synonyms":["10% sodium chloride injection","B1655","Isotonic","LS-1700","NSC-77364","RNS-60 COMPONENT SALINE","RNS60 COMPONENT SALINE","SALINE SOLUTION","Sea water","Sodium Chloride, Hypertonic","Sodium chloride","Sodium chloride solution","Sodium chloride, hypertonic"],"crossReferences":{"DailyMed":["sodium%20chloride"],"DrugCentral":["4198"],"Wikipedia":["Sodium_chloride"],"drugbank":["DB09153"],"chEBI":["26710"]},"childChemblIds":["CHEMBL2103896"],"count":298,"approvedIndications":["EFO_0003966","MP_0001914"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for eye disease and hemorrhage and has 296 investigational indications."}
{"id":"CHEMBL1200617","canonicalSmiles":"CCC(=O)[C@@]1(C)[C@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C","inchiKey":"QTTRZHGPGKRAFB-OOKHYKNYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIMEXOLONE","yearOfFirstApproval":1994,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vexol"],"synonyms":["ORG 6216","ORG-6216","Rimexolone"],"crossReferences":{"PubChem":["56463550"],"Wikipedia":["Rimexolone"],"drugbank":["DB00896"]},"count":2,"approvedIndications":["EFO_0005752"],"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_1000906","EFO_0005752"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1994 and is indicated for eye inflammation and has 1 investigational indication."}
{"id":"CHEMBL1200772","canonicalSmiles":"CC(=O)CC(c1ccccc1)c1c([O-])c2ccccc2oc1=O.[K+]","inchiKey":"WSHYKIAQCMIPTB-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"WARFARIN POTASSIUM","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1464","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Athrombin-k"],"synonyms":["Warfarin potassium"],"crossReferences":{"PubChem":["144205190","170464790"]},"count":3,"linkedTargets":{"rows":["ENSG00000167397"],"count":1},"linkedDiseases":{"rows":["HP_0001907","EFO_0000275","EFO_0003907"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and has 3 investigational indications."}
{"id":"CHEMBL1200806","canonicalSmiles":"COc1ccc2cc([C@H](C)C(=O)[O-])ccc2c1.[Na+]","inchiKey":"CDBRNDSHEYLDJV-FVGYRXGTSA-M","drugType":"Small molecule","blackBoxWarning":true,"name":"NAPROXEN SODIUM","yearOfFirstApproval":1980,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL154","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aleve","Anaprox","Anaprox ds","Naprelan","Naproxen sodium","Synflex"],"synonyms":["BAY-117031","BAY117031","BAYH6689","Naproxen sodium","Naproxen sodium salt","RS-3650"],"crossReferences":{"DailyMed":["naproxen%20sodium"],"PubChem":["11112047","11113013","144204325","170465301","50106619","85231338","855887"],"chEBI":["7477"]},"count":15,"approvedIndications":["EFO_0000685","EFO_0002506","EFO_0003821","EFO_0004274","EFO_0003898","HP_0100607","EFO_0003843","EFO_1001434","EFO_1000941","EFO_0002609"],"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["EFO_0000685","EFO_0003821","EFO_0004274","EFO_0010072","EFO_0000249","EFO_0003898","HP_0000132","EFO_0003843","EFO_1000941","EFO_0002609","EFO_0009454","EFO_0002506","EFO_0000731","EFO_0004616","HP_0100607","MONDO_0002258","EFO_1001434"],"count":17},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1980 and has 10 approved and 5 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200972","canonicalSmiles":"CN(C)CCC(O)(c1ccccc1)c1ccccc1Cl.Cl","inchiKey":"XYGSFNHCFFAJPO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLOPHEDIANOL HYDROCHLORIDE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201313","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Chlophedianol hydrochloride","Clofedanol hydrochloride","SL 501","SL-501"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1201567","drugType":"Protein","blackBoxWarning":false,"name":"FILGRASTIM","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Accofil","Neupogen","Neupogen 30","Neupogen 48","Nivestim","Zarzio"],"synonyms":["Filgrastim","Filgrastim-sndz","Granulocyte colony-stimulating factor filgrastim","KRN-8601","MBRI-9901","R-METHUG-CSF","TX-01","TX01","Tbo-filgrastim","XM-02","XM02"],"crossReferences":{"DailyMed":["filgrastim","filgrastim-aafi","filgrastim-sndz","tbo-filgrastim"],"DrugCentral":["4987"],"Wikipedia":["Filgrastim"]},"count":159,"approvedIndications":["MONDO_0001475"],"linkedTargets":{"rows":["ENSG00000119535"],"count":1},"linkedDiseases":{"rows":["HP_0012410","EFO_0000637","EFO_0004708","EFO_0003859","MONDO_0003751","EFO_0000756","EFO_0000249","EFO_0000681","EFO_1000231","HP_0031217","EFO_0005952","EFO_1001345","EFO_1000984","Orphanet_85443","EFO_1001951","EFO_0006803","EFO_1001952","EFO_1000318","MONDO_0015760","EFO_0000339","EFO_0000096","EFO_0002690","MONDO_0002974","MONDO_0008903","EFO_1000632","EFO_0002918","EFO_0000514","EFO_0004991","EFO_0000760","EFO_0000407","EFO_0000198","EFO_0002618","MONDO_0013730","EFO_0000221","MONDO_0019465","EFO_0001642","EFO_1001946","EFO_1001968","EFO_0000384","MONDO_0008315","HP_0001399","MONDO_0002691","EFO_0001422","EFO_1001365","EFO_0003032","MONDO_0044889","MONDO_0018201","EFO_0000574","EFO_0004256","EFO_0001378","EFO_1000796","EFO_1000550","EFO_0001376","Orphanet_84","MONDO_0044903","EFO_0000292","Orphanet_303","EFO_0007416","EFO_0007498","EFO_1001465","MONDO_0007254","Orphanet_790","EFO_0004252","MONDO_0003541","MONDO_0020654","EFO_0002430","MONDO_0001056","MONDO_0002158","EFO_1001974","EFO_0004289","EFO_1000630","EFO_0000196","EFO_0000183","EFO_0000616","EFO_0006859","EFO_1001779","MONDO_0019457","EFO_0001645","EFO_0000403","EFO_1001042","EFO_0000222","MONDO_0000870","EFO_0003929","MONDO_0007576","EFO_1001953","EFO_1000954","EFO_0003885","EFO_0000764","EFO_0007359","MONDO_0011962","EFO_0000702","EFO_1001947","MONDO_0002367","EFO_0006927","MONDO_0018906","MONDO_0024880","EFO_0004265","MONDO_0000873","EFO_0003869","EFO_0004281","Orphanet_183660","MONDO_0003783","MONDO_0000956","EFO_1000131","MONDO_0004222","EFO_0000565","EFO_0000309","EFO_0004251","Orphanet_178","HP_0001871","EFO_0000389","HP_0008209","MONDO_0019460","EFO_0000330","MONDO_0019088","EFO_0000182","EFO_0000253","EFO_1000749","Orphanet_654","EFO_0009441","EFO_0003802","EFO_0003893","EFO_0000466","EFO_0000220","EFO_0004145","EFO_0002508","MONDO_0008170","EFO_0000223","EFO_0002939","MONDO_0044881","EFO_0000224","EFO_0003025","EFO_0009708","EFO_0006926","MONDO_0001208","EFO_1000238","EFO_0005537","EFO_0001359","EFO_0002428","EFO_0000218","EFO_0003922","Orphanet_30391","MONDO_0009348","MONDO_0019471","EFO_0003812","Orphanet_232","MONDO_0004192","MONDO_0044887","EFO_1001945","EFO_1001469","HP_0001915","MONDO_0002087","MONDO_0002041","EFO_1001311","EFO_0000209","EFO_1000357","MONDO_0001187","EFO_0007362","EFO_1000218","EFO_1000043","MONDO_0001475","EFO_0000712","MONDO_0001657","EFO_0004272","MONDO_0020743","EFO_0000717","EFO_1001963","EFO_0000239","EFO_1000158","EFO_0003928","HP_0002140","EFO_0000545","EFO_0003875","EFO_0005529","HP_0001945","EFO_0000556","EFO_0000313","EFO_0000621","EFO_0003060","EFO_0003029","EFO_0000311","EFO_0000211","EFO_0006861","EFO_0000095","EFO_0005235","EFO_0006475","EFO_0000174","EFO_0001421","EFO_0000191","EFO_0004142","EFO_0008583","EFO_0000612","MONDO_0020077","EFO_0003833","EFO_0000691","MONDO_0004643","EFO_0000181","EFO_0003811","EFO_0003027"],"count":199},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1991 and is indicated for neutropenia and has 158 investigational indications."}
{"id":"CHEMBL1201644","drugType":"Protein","blackBoxWarning":false,"name":"INSULIN ZINC SUSP RECOMBINANT HUMAN","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Humulin l","Novolin l"],"synonyms":["Insulin zinc susp recombinant human"],"count":1,"linkedTargets":{"rows":["ENSG00000171105"],"count":1},"linkedDiseases":{"rows":["EFO_0000400"],"count":1},"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1985 and has 1 investigational indication."}
{"id":"CHEMBL1201754","canonicalSmiles":"NC(=O)c1cn(Cc2c(F)cccc2F)nn1","inchiKey":"POGQSBRIGCQNEG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RUFINAMIDE","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Banzel","Inovelon","Rufinamide"],"synonyms":["60231/4","CGP 33101","CGP-33101","E-2080","E2080","RUF 331","RUF-331","Rufinamide"],"crossReferences":{"DailyMed":["rufinamide"],"PubChem":["170465202","29217641","50111716","56320687","90341717"],"Wikipedia":["Rufinamide"],"drugbank":["DB06201"]},"count":4,"approvedIndications":["EFO_0000474","Orphanet_2382"],"linkedTargets":{"rows":["ENSG00000185313","ENSG00000153253","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000007314","ENSG00000136531","ENSG00000196876"],"count":10},"linkedDiseases":{"rows":["EFO_0000474","HP_0001250","Orphanet_2382","EFO_0003843"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and is indicated for lennox-gastaut syndrome and epilepsy and has 2 investigational indications."}
{"id":"CHEMBL1201798","canonicalSmiles":"C=CCN.ClCC1CO1","inchiKey":"ZNSIZMQNQCNRBW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SEVELAMER","yearOfFirstApproval":2007,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Renagel","Renvela"],"synonyms":["Sevelamer"],"crossReferences":{"DailyMed":["sevelamer%20carbonate"],"DrugCentral":["4324"],"drugbank":["DB00658"]},"childChemblIds":["CHEMBL1201799"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2007."}
{"id":"CHEMBL1213604","canonicalSmiles":"CCCC1=N[C@H]2[C@H](O[C@H](CO)[C@@H](O)[C@@H]2O)S1","inchiKey":"QWOPEBCGKASVQP-QXOHVQIXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1213604","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08255"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1214598","canonicalSmiles":"CCOC(=O)c1c(CSc2ccccc2)n(C)c2cc(Br)c(O)c(CN(C)C)c12","inchiKey":"KCFYEAOKVJSACF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"UMIFENOVIR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Arbidol","Umifenovir"],"crossReferences":{"PubChem":["26662180"],"drugbank":["DB13609"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1233524","canonicalSmiles":"CN(C)CCN(C)[C@H]1COc2ccccc2-c2c(C3CCCCC3)c3ccc(C(=O)O)cc3n2C1","inchiKey":"YQUCBFIQSJVCOR-JOCHJYFZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MK-3281","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-3281","Mk-3281"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1233881","canonicalSmiles":"COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC","inchiKey":"ITOYZJGFTNTKKR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1233881","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08053"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234416","canonicalSmiles":"Cc1nc(N)nc2c1/C(=N/O)C[C@@H](c1ccc(F)cc1-c1cccnc1)C2","inchiKey":"KYIXUSLGFINPTC-WVFAEZDRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234416","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08197"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234777","canonicalSmiles":"N=C(NO)NCC[C@H](N)C(=O)O","inchiKey":"KOBHCUDVWOTEKO-VKHMYHEASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234777","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02381"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235478","drugType":"Small molecule","blackBoxWarning":false,"name":"PLATINUM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Platinum"],"crossReferences":{"chEBI":["33364"]},"count":6,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL1236642","canonicalSmiles":"CCCCCC/C=C\\CCCCCCCCCC(=O)O","inchiKey":"UWHZIFQPPBDJPM-FPLPWBNLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VACCENIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Vaccenic acid"],"crossReferences":{"drugbank":["DB04801"],"chEBI":["50464"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236962","canonicalSmiles":"COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F","inchiKey":"CGBJSGAELGCMKE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OMIPALISIB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK-2126458","GSK2126458","Gsk-2126458","Omipalisib"],"crossReferences":{"drugbank":["DB12703"]},"count":3,"linkedTargets":{"rows":["ENSG00000145675","ENSG00000171608","ENSG00000105647","ENSG00000141506","ENSG00000051382","ENSG00000121879","ENSG00000105851","ENSG00000117461","ENSG00000198793"],"count":9},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000768","EFO_0000311"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1237174","canonicalSmiles":"NN","inchiKey":"OAKJQQAXSVQMHS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDRAZINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Diamine","Diazane","Hydrazine"],"crossReferences":{"Wikipedia":["Hydrazine"],"chEBI":["15571"]},"childChemblIds":["CHEMBL542171","CHEMBL1981828"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1256717","canonicalSmiles":"Cc1cc(C)c(NC(=O)C[C@H](CC(=O)O)c2cccc3ccccc23)c(C(=O)N2CCC3(CCCC3)CC2)c1","inchiKey":"MFOOVZCXWVAWOV-RUZDIDTESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ITRIGLUMIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cr-2945","Itriglumide"],"crossReferences":{"PubChem":["50111121"]},"childChemblIds":["CHEMBL1335406"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL128748","canonicalSmiles":"COc1ccc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(OC)c(OC)c2)cc1OC","inchiKey":"ZMGUKFHHNQMKJI-CIOHCNBKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIMETHYLCURCUMIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ASCJ-9","CHC-004","Dimethylcurcumin","GO-Y-025","Go-Y025"],"crossReferences":{"drugbank":["DB06133"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1334078","canonicalSmiles":"[Na+].[O-]Cl","inchiKey":"SUKJFIGYRHOWBL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM HYPOCHLORITE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL1616046","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Actichlor","Chlorasol","Milton in emuls wax","Milton in liq paraf","Milton no.2"],"synonyms":["Antiformin, dental","Dental antiformin","Sodium hypochlorite","Sodium hypochlorite [solution, diluted]"],"crossReferences":{"DrugCentral":["4790"],"PubChem":["17389733"],"chEBI":["32146"]},"count":5,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL141247","canonicalSmiles":"O=C(Nc1ccccn1)Nc1cccc2c1[C@H]1CCCN1C2=O","inchiKey":"KLVYMYQTRZCMLE-CYBMUJFWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL141247","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04186"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1420","canonicalSmiles":"C[n+]1ccccc1C=NO","inchiKey":"JBKPUQTUERUYQE-UHFFFAOYSA-O","drugType":"Small molecule","blackBoxWarning":false,"name":"PRALIDOXIME","yearOfFirstApproval":1964,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Atnaa","Duodote","Pralidoxime"],"crossReferences":{"DailyMed":["pralidoxime%20chloride"],"PubChem":["11112108"],"Wikipedia":["Pralidoxime"],"drugbank":["DB00733"],"chEBI":["8354"]},"childChemblIds":["CHEMBL3335073","CHEMBL748","CHEMBL2104739","CHEMBL14577"],"count":2,"linkedTargets":{"rows":["ENSG00000087085"],"count":1},"linkedDiseases":{"rows":["EFO_0010581","EFO_0008546"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1964 and has 2 investigational indications."}
{"id":"CHEMBL14249","canonicalSmiles":"Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1O","inchiKey":"ZKHQWZAMYRWXGA-KQYNXXCUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ADENOSINE TRIPHOSPHATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Adenosine triphosphate"],"crossReferences":{"PubChem":["144205597","26514303","26756664"],"Wikipedia":["Adenosine_triphosphate"],"drugbank":["DB00171"],"chEBI":["15422"]},"childChemblIds":["CHEMBL1447572","CHEMBL2364734","CHEMBL2364735","CHEMBL2106579"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1448187","canonicalSmiles":"Cl.Cl.OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1","inchiKey":"MBHNWCYEGXQEIT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"FLUPHENAZINE HYDROCHLORIDE","yearOfFirstApproval":1959,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL726","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fluphenazine hydrochloride","Moditen","Permitil","Prolixin"],"synonyms":["Fluphenazine dihydrochloride","Fluphenazine hydrochloride","NSC-179197","SQUIBB 4918"],"crossReferences":{"DailyMed":["fluphenazine%20hydrochloride"],"PubChem":["26747520","26747521","50106350"]},"count":1,"linkedTargets":{"rows":["ENSG00000149295"],"count":1},"linkedDiseases":{"rows":["EFO_0001378"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1959 and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL150","canonicalSmiles":"O=c1c(O)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12","inchiKey":"IYRMWMYZSQPJKC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"KAEMPFEROL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Kaempferol","Kempferol","Pelargidenolon","Populnetin","Rhamnolutein","Rhamnolutin","Robigenin","Swartziol","Trifolitin"],"crossReferences":{"PubChem":["11112381","11112382","124882309","144208363","144213678","17389844","174007227","26757741","46501187","49674535","50105504"],"Wikipedia":["Kaempferol"],"drugbank":["DB01852"],"chEBI":["28499"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1512","canonicalSmiles":"CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1","inchiKey":"XSFJVAJPIHIPKU-XWCQMRHXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUNISOLIDE","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aerobid","Aerospan","Aerospan hfa","Flunisolide","Nasalide","Nasarel","Syntaris","Syntaris hayfever"],"synonyms":["Flunisolide","Flunisolide hemihydrate","RS-3999"],"crossReferences":{"DailyMed":["flunisolide"],"PubChem":["144204276","170465331","56463079"],"Wikipedia":["Flunisolide"],"drugbank":["DB00180"],"chEBI":["5106"]},"count":4,"approvedIndications":["HP_0006536","EFO_0000270","HP_0001742"],"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["HP_0006536","EFO_0000270","EFO_1001417","HP_0001742"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1981 and has 3 approved and 1 investigational indication."}
{"id":"CHEMBL1522","canonicalSmiles":"CN1CCN(C(=O)O[C@H]2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1","inchiKey":"GBBSUAFBMRNDJC-INIZCTEOSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ESZOPICLONE","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Eszopiclone","Lunesta"],"synonyms":["(S)-ZOPICLONE","(S)-Zopiclone","Eszopiclone","Eszopiclone civ","GSK-1755165","Zopiclone s-form"],"crossReferences":{"DailyMed":["eszopiclone"],"PubChem":["144205286","170465445","29215492","49666409"],"Wikipedia":["Eszopiclone"],"drugbank":["DB00402"],"chEBI":["53760"]},"count":3,"approvedIndications":["EFO_0004698"],"linkedTargets":{"rows":["ENSG00000182256","ENSG00000022355","ENSG00000011677","ENSG00000113327","ENSG00000163285","ENSG00000151834","ENSG00000186297"],"count":7},"linkedDiseases":{"rows":["EFO_0007191","EFO_1001892","EFO_0001358","EFO_0003918","EFO_0004698"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and is indicated for insomnia and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1552157","canonicalSmiles":"CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C","inchiKey":"PRAKJMSDJKAYCZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SQUALANE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Squalane"],"crossReferences":{"PubChem":["144205830","170465658","29217734"],"drugbank":["DB11420"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL15768","canonicalSmiles":"CC12CCC(CC1=O)C2(C)C","inchiKey":"DSSYKIVIOFKYAU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL15768","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144207435"],"Wikipedia":["Camphor"],"drugbank":["DB14156"],"chEBI":["36773"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1590946","canonicalSmiles":"NC(=O)c1cc[n+](CC2=C(C(=O)[O-])N3C(=O)[C@@H](NC(=O)[C@@H](c4ccccc4)S(=O)(=O)[O-])[C@H]3SC2)cc1.[Na+]","inchiKey":"REACMANCWHKJSM-DWBVFMGKSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFSULODIN SODIUM","maximumClinicalTrialPhase":4,"parentId":"CHEMBL3351077","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cefomonil","Monaspor"],"synonyms":["ABBOTT-46811","CGP-71741E","Cefsulodin sodium"],"crossReferences":{"PubChem":["124891625","50106012"],"chEBI":["31380"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL15913","canonicalSmiles":"Nc1cc[nH]c(=O)n1","inchiKey":"OPTASPLRGRRNAP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYTOSINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cytosine","Lamivudine impurity c","Lamivudine impurity c rs","NSC-27787"],"crossReferences":{"PubChem":["144212456","56322619"],"Wikipedia":["Cytosine"],"chEBI":["16040"]},"childChemblIds":["CHEMBL2028229"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL159820","canonicalSmiles":"O=C(O)Cn1ccc(=O)n(Cc2nc3cc(Cl)ccc3s2)c1=O","inchiKey":"RQWICELTTDJODO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL159820","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07093"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1618116","canonicalSmiles":"CSc1nc2[nH]nc([N+](=O)[O-])c(=O)n2n1","inchiKey":"IDVQGNMSSHPZSJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1618116","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB15622"]},"childChemblIds":["CHEMBL1256733"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1651913","canonicalSmiles":"COc1cccc(C(=O)CCN[C@@H](C)[C@H](O)c2ccccc2)c1","inchiKey":"GDYUVHBMFVMBAF-LIRRHRJNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXYFEDRINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Oxyfedrine","Oxyfedrine hydrochloride"],"crossReferences":{"drugbank":["DB13398"]},"childChemblIds":["CHEMBL2354521"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1665","canonicalSmiles":"CCC[S+]([O-])c1ccc2[nH]c(NC(=O)OC)nc2c1","inchiKey":"VXTGHWHFYNYFFV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALBENDAZOLE OXIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Albendazole oxide"],"crossReferences":{"PubChem":["170466291","174006227"],"drugbank":["DB13871"],"chEBI":["16959"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1694","canonicalSmiles":"CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CCc2ccccc2N(CC(=O)O)C1=O.Cl","inchiKey":"VPSRQEHTHIMDQM-FKLPMGAJSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"BENAZEPRIL HYDROCHLORIDE","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL838","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Benazepril hydrochloride","Cibacen","Lotensin"],"synonyms":["Benazepril hydrochloride","CGS 14824A HCL","CGS-14824A","CGS-14824A HCL"],"crossReferences":{"DailyMed":["benazepril%20hydrochloride"],"PubChem":["144204994","170465003","49648469"],"chEBI":["3012"]},"count":3,"approvedIndications":["EFO_0000537"],"linkedTargets":{"rows":["ENSG00000159640"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","Orphanet_79292","EFO_0000537"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1991 and is indicated for hypertension and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1712","canonicalSmiles":"Cl.O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1","inchiKey":"NZDBKBRIBJLNNT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZIPRASIDONE HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL708","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Ziprasidone HCl"],"synonyms":["CP-88059-1"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1743053","drugType":"Antibody","blackBoxWarning":false,"name":"OTELIXIZUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CHAGLY CD3","CHAGLYCD-3","ChAglyCD","Chaglycd3","Otelixizumab","TRX-4","TRX4"],"count":3,"linkedTargets":{"rows":["ENSG00000198851"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","EFO_0001359","EFO_1001466"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL183","canonicalSmiles":"CCCn1c(=O)c2[nH]c(C3CCCC3)nc2n(CCC)c1=O","inchiKey":"FFBDFADSZUINTG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"1,3-DIPROPYL-8-CYCLOPENTYLXANTHINE [DPCPX]","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GNF-Pf-2224"],"crossReferences":{"PubChem":["11110874","11113351","50104134","56422903","85230944","855876","90341492"],"Wikipedia":["Dipropylcyclopentylxanthine"],"drugbank":["DB12946"],"chEBI":["73282"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL184048","canonicalSmiles":"N=C(N)c1ccc(CO)cc1","inchiKey":"WHMKAFNJMLEDSN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"4-Hydroxymethyl-Benzamidine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-Hydroxymethyl-Benzamidine"],"crossReferences":{"drugbank":["DB02585"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL185595","canonicalSmiles":"O=C(O)CCCn1c2ccccc2c2ccccc21","inchiKey":"HQAKVYGASUTQHH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL185595","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03851"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL18591","canonicalSmiles":"O=C(O)C1=NCCC1","inchiKey":"RHTAIKJZSXNELN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL18591","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02838"],"chEBI":["36761"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL208427","canonicalSmiles":"O=C(O)c1cccc(-c2cccc(NCCNC[C@H](O)c3cccc(Cl)c3)c2)c1","inchiKey":"LLDXOPKUNJTIRF-QFIPXVFZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SOLABEGRON","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gw427353","Solabegron"],"crossReferences":{"drugbank":["DB06190"]},"childChemblIds":["CHEMBL2107299"],"count":1,"linkedTargets":{"rows":["ENSG00000188778"],"count":1},"linkedDiseases":{"rows":["EFO_1000781"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2103881","canonicalSmiles":"CN[C@@]1(C)[C@@H]2CC[C@@H](C2)C1(C)C","inchiKey":"IMYZQPCYWPFTAG-NGZCFLSTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXMECAMYLAMINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dexmecamylamine","NIH-11008","TC-5214","Tc-5214"],"crossReferences":{"drugbank":["DB11807"]},"childChemblIds":["CHEMBL2105753"],"count":6,"linkedTargets":{"rows":["ENSG00000160716","ENSG00000101204"],"count":2},"linkedDiseases":{"rows":["EFO_0003086","EFO_0003890","MONDO_0002009","HP_0000975","EFO_1000781","EFO_0000537"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL2104103","canonicalSmiles":"NC(=O)C1(N2CCCCC2)CCN(CCCN2c3ccccc3CCc3ccc(Cl)cc32)CC1","inchiKey":"QAZKXHSIKKNOHH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLOCAPRAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Clocapramine","Clocapramine hydrochloride","Y 4153 [AS HYDROCHLORIDE]"],"crossReferences":{"PubChem":["170465785"],"drugbank":["DB09003"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2104859","canonicalSmiles":"Cc1ncc(COC(=O)CCC(=O)OCCN(C)C)c(CO)c1O","inchiKey":"KTOAWCPDBUCJED-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIRISUDANOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pirisudanol"],"crossReferences":{"drugbank":["DB13412"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2105085","canonicalSmiles":"CC(C)=CCC/C(C)=C/CC/C(C)=C/CCC(=O)OC/C=C(\\C)CCC=C(C)C","inchiKey":"ZPACYDRSPFRDHO-ROBAGEODSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GEFARNATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DA 688","DA-688","Gefarnate"],"crossReferences":{"PubChem":["144206536","170465908"],"drugbank":["DB12079"]},"count":5,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2105700","canonicalSmiles":"COc1nc2ccc(Br)cc2cc1[C@@H](c1ccccc1)[C@@](O)(CCN(C)C)c1cccc2ccccc12.O=C(O)/C=C/C(=O)O","inchiKey":"ZLVSPMRFRHMMOY-WWCCMVHESA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"BEDAQUILINE FUMARATE","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL376488","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Sirturo"],"synonyms":["Bedaquiline fumarate","R403323"],"crossReferences":{"DailyMed":["bedaquiline%20fumarate"],"chEBI":["72295"]},"count":1,"approvedIndications":["Orphanet_3389"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2012 and is indicated for tuberculosis. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2105710","canonicalSmiles":"CCCCC[C@H](O)c1ccc(N2C(=O)CC[C@@H]2COCc2ccc(C(=O)OC(C)C)s2)cc1","inchiKey":"MSIIJNOQQWRTFC-GGAORHGYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SIMENEPAG ISOPROPYL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AGN-210669","Simenepag isopropyl"],"crossReferences":{"drugbank":["DB12977"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2105743","canonicalSmiles":"COc1ccc(CC(C)(C)NC[C@H](O)c2cc(O)cc3c2OCC(=O)N3)cc1.Cl","inchiKey":"KCEHVJZZIGJAAW-FERBBOLQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OLODATEROL HYDROCHLORIDE","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL605846","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Striverdi respimat"],"synonyms":["BI 1744 CL","BI-1744 CL","BI-1744-CL","Olodaterol hydrochloride"],"crossReferences":{"DailyMed":["olodaterol%20hydrochloride"],"chEBI":["83309"]},"count":2,"approvedIndications":["EFO_0000464","EFO_0000341"],"linkedTargets":{"rows":["ENSG00000169252"],"count":1},"linkedDiseases":{"rows":["EFO_0000464","EFO_0000341"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and is indicated for emphysema and chronic obstructive pulmonary disease."}
{"id":"CHEMBL2105747","canonicalSmiles":"COc1ccc(N2CCOCC2)c2sc(NC(=O)N3CCC(C)(O)CC3)nc12","inchiKey":"XNBRWUQWSKXMPW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TOZADENANT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A-2A (3)","A2A (3)","A2A-(3)","RO-4494351","RO-4494351-000","RO-4494351-002","RO-4494351000","RO4494351","RO4494351-000","RO4494351-002","SYN-115","SYN115","Tozadenant"],"crossReferences":{"drugbank":["DB12203"]},"count":3,"linkedTargets":{"rows":["ENSG00000128271"],"count":1},"linkedDiseases":{"rows":["EFO_0002610","EFO_0002508","EFO_0001421"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2105996","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)C(C(=O)Oc3ccccc3)c3ccccc3)C(=O)N2[C@H]1C(=O)[O-].[Na+]","inchiKey":"JXSBZDNBNJTHBJ-JPZUGYNPSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBENICILLIN PHENYL SODIUM","maximumClinicalTrialPhase":4,"parentId":"CHEMBL1095283","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Uticillin"],"synonyms":["BRL-3475","Carbenicillin phenyl sodium","Carfecillin sodium"],"crossReferences":{"chEBI":["34612"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL2106389","canonicalSmiles":"CNC(=O)c1c(I)c(NC(=O)CCCCC(=O)Nc2c(I)c(C(=O)O)c(I)c(C(=O)NC)c2I)c(I)c(C(=O)O)c1I","inchiKey":"SMQYOVYWPWASGU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IOCARMIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Iocarmic acid","MP 2032"],"crossReferences":{"PubChem":["170465965"],"drugbank":["DB13755"]},"childChemblIds":["CHEMBL3989542"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2106572","canonicalSmiles":"Cc1ccc(N2CCNCC2)c(S(=O)(=O)O)c1","inchiKey":"DCDFLGVJWQIRGH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CALDARET","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Caldaret"],"crossReferences":{"drugbank":["DB06231"]},"childChemblIds":["CHEMBL4297401"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2107720","canonicalSmiles":"CC(=O)CCC1C(=O)N(c2ccccc2)N(c2ccccc2)C1=O","inchiKey":"LGYTZKPVOAIUKX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"KEBUZONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cetophenylbutazone","Kebuzone","Ketophenylbutazone"],"crossReferences":{"drugbank":["DB08940"],"chEBI":["31749"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2107787","canonicalSmiles":"CC(=O)O[C@@]12CO[C@@H]1CC[C@@]1(C)[C@@H]3O[C@H](CN(C)C)O[C@@H]3C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ncccc4F)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C","inchiKey":"MODVSQKJJIBWPZ-VLLPJHQWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TESETAXEL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tesetaxel"],"crossReferences":{"drugbank":["DB12019"]},"count":6,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL2107875","drugType":"Small molecule","blackBoxWarning":false,"name":"PATIROMER","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Patiromer"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2107960","drugType":"Unknown","blackBoxWarning":false,"name":"POISON IVY EXTRACT, ALUM PRECIPITATED","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Aqua ivy, ap","Rhus tox antigen"],"synonyms":["Poison ivy","Poison ivy extract, alum precipitated","Rhus radicans leaf"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2108018","drugType":"Antibody","blackBoxWarning":false,"name":"ADECATUMUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Adecatumumab","MT-201"],"count":1,"linkedTargets":{"rows":["ENSG00000119888"],"count":1},"linkedDiseases":{"rows":["EFO_1001951"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2108020","drugType":"Unknown","blackBoxWarning":false,"name":"BCG LIVE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bcg live","Bcg vaccine live intradermal (tice)"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108076","drugType":"Unknown","blackBoxWarning":false,"name":"PARAFFIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FEMA NO. 3216","Paraffin"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2108309","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"CUSTIRSEN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Custirsen","ISIS-112989 FREE ACID","OGX-011 FREE ACID"],"count":3,"description":"Oligonucleotide drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2108336","drugType":"Protein","blackBoxWarning":false,"name":"LIXISENATIDE","yearOfFirstApproval":2016,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Adlyxin","Lyxumia"],"synonyms":["AVE 010","AVE-0010","AVE-010","AVE0010","Lixisenatide","ZP 10","ZP-10"],"crossReferences":{"DailyMed":["lixisenatide"]},"count":5,"approvedIndications":["EFO_0001360","EFO_0000400"],"linkedTargets":{"rows":["ENSG00000112164"],"count":1},"linkedDiseases":{"rows":["EFO_0002508","EFO_0001359","EFO_0001360","EFO_0000400","EFO_0005672"],"count":5},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2016 and is indicated for diabetes mellitus and type ii diabetes mellitus and has 3 investigational indications."}
{"id":"CHEMBL2108351","drugType":"Protein","blackBoxWarning":false,"name":"VOTUCALIS","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["REV-131","Rev131","Votucalis"],"count":1,"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2108446","drugType":"Unknown","blackBoxWarning":false,"name":"GUAR GUM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Glucotard","Guarina","Lejguar"],"synonyms":["Guar gum"],"count":1,"approvedIndications":["EFO_0000400"],"description":"Unknown drug with a maximum clinical trial phase of IV and is indicated for diabetes mellitus."}
{"id":"CHEMBL2108465","drugType":"Unknown","blackBoxWarning":false,"name":"GINGER","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Phillips","Travel sickness","Travelcaps"],"synonyms":["B1265","FEMA NO. 2520","FEMA NO. 2521","Ginger","Zingiber officinale","Zingiber officinale extract","Zingiber officinale rhizome","Zingiber officinale rhizome powder","Zingiber officinale rhizome tincture","Zingiber officinale root"],"count":12,"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) and has 12 investigational indications."}
{"id":"CHEMBL2108569","drugType":"Protein","blackBoxWarning":false,"name":"INSULIN PEGLISPRO","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Insulin peglispro","LY-2605541","LY2605541"],"count":2,"linkedTargets":{"rows":["ENSG00000171105"],"count":1},"linkedDiseases":{"rows":["EFO_0001359","EFO_0001360"],"count":2},"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108682","drugType":"Cell","blackBoxWarning":false,"name":"TERGENPUMATUCEL-L","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tergenpumatucel-l"],"count":1,"description":"Cell drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2108721","drugType":"Protein","blackBoxWarning":false,"name":"CENDERITIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CD-NP","Cenderitide"],"count":3,"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2108881","drugType":"Antibody","blackBoxWarning":false,"name":"SEVIRUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Protovir"],"synonyms":["EV2-7","MSL-109","SDZ MSL 109","Sevirumab"],"count":2,"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2109385","drugType":"Antibody","blackBoxWarning":false,"name":"ENOTICUMAB","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Enoticumab","REGN-421"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109582","drugType":"Antibody","blackBoxWarning":false,"name":"81C6 131I","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["81C6","81c6 131i"],"linkedTargets":{"rows":["ENSG00000041982"],"count":1},"linkedDiseases":{"rows":["MONDO_0024880","EFO_0000621","EFO_1000158"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2135756","canonicalSmiles":"COc1ccc2c3c1O[C@H]1C(=O)CC[C@H]4[C@@H](C2)N(C)CC[C@]314.O.O=P(O)(O)O","inchiKey":"OASMLEYVQTUFOZ-RLWSFTDUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2135756","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1457","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["50086519"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2146102","canonicalSmiles":"CN[C@@H](C)[C@H](O)c1ccccc1.Cl","inchiKey":"BALXUFOVQVENIU-GNAZCLTHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EPHEDRINE HYDROCHLORIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL211456","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Amesec","Asmapax","Bronchipax","C.a.m.","Do-do","Ephed hcl","Ephed in nor saline","Expurhin","Franol","Haymine","Secron","Tabasan","Taumasthman","Tedral","Tedral sa"],"synonyms":["Ephedrine hydrochloride"],"crossReferences":{"PubChem":["144204863","170465509"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL21485","canonicalSmiles":"OB(O)c1ccccc1","inchiKey":"HXITXNWTGFUOAU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENYLBORONIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Phenylboronic Acid"],"crossReferences":{"Wikipedia":["Phenylboronic_acid"],"drugbank":["DB01795"],"chEBI":["44923"]},"childChemblIds":["CHEMBL2207070"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL217068","canonicalSmiles":"N=C(N)NC(=O)Cn1c(-c2ccccc2)ccc1-c1ccccc1","inchiKey":"WVLDNAVUCUAGDP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL217068","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06930"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2237502","canonicalSmiles":"COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC.O=C(O)/C=C\\C(=O)O","inchiKey":"INJBQHPKOUHXSH-BTJKTKAUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIMETHOPRIM MALEIC ACID SALT","maximumClinicalTrialPhase":0,"parentId":"CHEMBL22","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL225157","canonicalSmiles":"CCOC(=O)C1=CCCC[C@H]1S(=O)(=O)Nc1ccc(F)cc1Cl","inchiKey":"LEEIJTHMHDMWLJ-CQSZACIVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RESATORVID","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Resatorvid","TAK-242"],"crossReferences":{"drugbank":["DB05943"]},"childChemblIds":["CHEMBL3527013"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL226335","canonicalSmiles":"C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(-c4ccc(O)c(O)c4)oc4cc(O)cc(O)c4c3=O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O","inchiKey":"IKGXIBQEEMLURG-NVPNHPEKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RUTIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["C.I. 75730","NSC-115918","NSC-9220","Rutin","Rutoside"],"crossReferences":{"PubChem":["144205498","144209800","170465691","26719694","29216321"],"drugbank":["DB01698"],"chEBI":["28527"]},"childChemblIds":["CHEMBL455260","CHEMBL1883743"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2303613","canonicalSmiles":"CO/N=C(\\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(CSc3nc(C)c(CC(=O)O)s3)CS[C@H]12)c1csc(N)n1","inchiKey":"XDZKBRJLTGRPSS-BGZQYGJUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFODIZIME","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Timecef"],"synonyms":["Cefodizime","Cefodizime sodium","HR 221 [AS SODIUM]","S 77 1221 B [AS SODIUM]","THR 221 [AS SODIUM]"],"crossReferences":{"drugbank":["DB13470"],"chEBI":["63214"]},"childChemblIds":["CHEMBL3189077"],"count":1,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for bacterial disease."}
{"id":"CHEMBL238103","canonicalSmiles":"COc1ncc(OC)c2c(C(=O)C(=O)N3CCN(C(=O)c4ccccc4)CC3)c[nH]c12","inchiKey":"DBPMWRYLTBNCCE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-488043","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-488043"],"crossReferences":{"drugbank":["DB05532"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL239857","canonicalSmiles":"COc1cccc(-c2cccc(CC[C@]3(C)CC(=O)N(C)C(N)=N3)c2)c1","inchiKey":"VDFBMQAUECXNKR-OAQYLSRUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL239857","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07519"]},"childChemblIds":["CHEMBL2437435"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL25105","canonicalSmiles":"N=C(N)c1ccc(OCCCCCCOc2ccc(C(=N)N)cc2)cc1","inchiKey":"OQLKNTOKMBVBKV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HEXAMIDINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Hexamidine"],"crossReferences":{"Wikipedia":["Hexamidine"],"drugbank":["DB03808"],"chEBI":["87184"]},"childChemblIds":["CHEMBL561781","CHEMBL3216902"],"count":2,"approvedIndications":["EFO_1001888","HP_0001742"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for eye infection and nasal obstruction."}
{"id":"CHEMBL269864","canonicalSmiles":"O=c1[nH]cnc2c(CN3C[C@H](O)[C@@H](CO)C3)c[nH]c12","inchiKey":"AFNHHLILYQEHKK-BDAKNGLRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ULODESINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Bcx-4208"],"synonyms":["BCX-3408","BCX4208","R-3421","Ulodesine"],"crossReferences":{"drugbank":["DB12353"]},"childChemblIds":["CHEMBL2107835","CHEMBL1213653"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL270515","canonicalSmiles":"CC(C)C[C@H](NC(=O)[C@@H](NC(=O)c1cccc(-c2ccccc2)n1)[C@@H](C)O)B(O)O","inchiKey":"SJFBTAPEPRWNKH-CCKFTAQKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DELANZOMIB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CEP 18770","CEP-18770","CIP 18770","CIP-18770","CT 47098","CT-47098","Delanzomib","NPH 007098","NPH-007098","NPH007098"],"crossReferences":{"drugbank":["DB11956"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL274119","canonicalSmiles":"CSCCC(N)C(=O)O","inchiKey":"FFEARJCKVFRZRR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RACEMETHIONINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Pedameth"],"synonyms":["Dl-methionine","Methionine","Racemethionine"],"crossReferences":{"PubChem":["144205216"],"drugbank":["DB13972"],"chEBI":["16811"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL278819","canonicalSmiles":"Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1","inchiKey":"LDMWSLGGVTVJPG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MINAPRINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["France"],"classes":["Neurotoxicity"],"year":1996},"tradeNames":["Cantor"],"synonyms":["AGR-1240","Brantur","CB-30038","Cantor","Minaprine"],"crossReferences":{"PubChem":["11112706"],"Wikipedia":["Minaprine"],"drugbank":["DB00805"],"chEBI":["51038"]},"childChemblIds":["CHEMBL536932","CHEMBL1364551"],"count":1,"approvedIndications":["EFO_0003761"],"linkedTargets":{"rows":["ENSG00000184845","ENSG00000149295","ENSG00000189221","ENSG00000087085","ENSG00000168539"],"count":5},"linkedDiseases":{"rows":["EFO_0003761"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for unipolar depression. It was withdrawn in France  in 1996 due to Neurotoxicity."}
{"id":"CHEMBL281764","canonicalSmiles":"CNC(=O)[C@@H](Cc1ccccc1)N(C)C(=O)[C@@H](Cc1ccc2ccccc2c1)N(C)C(=O)/C=C/CC(C)(C)N","inchiKey":"WURGZWOTGMLDJP-ZCYANPAGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TABIMORELIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nn703","Tabimorelin"],"crossReferences":{"PubChem":["26753275"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL281786","canonicalSmiles":"CO[C@]12CC[C@@]3(C[C@@H]1C(C)(C)O)[C@H]1Cc4ccc(O)c5c4[C@@]3(CCN1CC1CC1)[C@H]2O5","inchiKey":"OIJXLIIMXHRJJH-KNLIIKEYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIPRENORPHINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["M50-50 injection"],"synonyms":["Diprenorphine"],"crossReferences":{"Wikipedia":["Diprenorphine"],"drugbank":["DB01548"],"chEBI":["4650"]},"childChemblIds":["CHEMBL2311186"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3039516","canonicalSmiles":"CCCCCCCC/C=C/CCCCCCCC(=O)OC[C@H]1O[C@@H](n2ccc(N)nc2=O)C(F)(F)[C@@H]1O","inchiKey":"HESSNRGIEVBPRB-QDDPNBLJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GEMCITABINE ELAIDATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CO-1.01","CO-101","CP-4126","Gemcitabine elaidate"],"crossReferences":{"drugbank":["DB12564"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL305686","canonicalSmiles":"Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)C[C@H]1O","inchiKey":"OFEZSBMBBKLLBJ-BAJZRUMYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CORDYCEPIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3'-Deoxyadenosine","Cordycepin","NSC-401022","NSC-63984"],"crossReferences":{"PubChem":["47193882"],"Wikipedia":["Cordycepin"],"drugbank":["DB12156"],"chEBI":["29014"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL311875","canonicalSmiles":"C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H](O)[C@H](N)Cc1ccccc1)C(N)=O","inchiKey":"YVUUZAPYLPWFHE-HXFGRODQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL311875","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04092"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3125702","canonicalSmiles":"CC(C)[C@@H](CS(=O)(=O)C(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1","inchiKey":"DRLCSJFKKILATL-YWCVFVGNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMG-232","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG-232","Amg 232","Amg-232","KRT-232","Krt-232","Mdm2 inhibitor amg-232"],"crossReferences":{"drugbank":["DB15299"]},"count":10,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 10 investigational indications."}
{"id":"CHEMBL3127326","canonicalSmiles":"COC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)Nc1ccc([C@@H]2CC[C@@H](c3ccc(NC(=O)[C@@H]4CCCN4C(=O)[C@@H](NC(=O)OC)C(C)C)cc3)N2c2ccc(C(C)(C)C)cc2)cc1)C(C)C","inchiKey":"PIDFDZJZLOTZTM-KHVQSSSXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OMBITASVIR","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["ABT-267","Ombitasvir"],"crossReferences":{"drugbank":["DB09296"],"chEBI":["85183"]},"count":4,"approvedIndications":["EFO_0004220","EFO_0003047"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and is indicated for chronic hepatitis c virus infection and hepatitis c virus infection and has 2 investigational indications."}
{"id":"CHEMBL3137691","canonicalSmiles":"CCN(CC)CCS(=O)(=O)[C@@H]1CCN2C(=O)c3coc(n3)CC(=O)C[C@H](O)/C=C(C)/C=C/CNC(=O)/C=C/[C@@H](C)[C@@H](C(C)C)OC(=O)[C@@H]12.CC[C@H]1NC(=O)[C@@H](NC(=O)c2ncccc2O)[C@@H](C)OC(=O)[C@H](c2ccccc2)NC(=O)[C@@H]2CC(=O)[C@H](CS[C@@H]3CN4CCC3CC4)CN2C(=O)[C@H](Cc2ccc(N(C)C)cc2)N(C)C(=O)[C@@H]2CCCN2C1=O","inchiKey":"PPKJUHVNTMYXOD-PZGPJMECSA-N","drugType":"Unknown","blackBoxWarning":false,"name":"QUINUPRISTIN/DALFOPRISTIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Synercid"],"synonyms":["Quinupristin/Dalfopristin","Quinupristin/dalfopristin","Synercid"],"count":3,"approvedIndications":["EFO_0000771"],"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) and is indicated for bacterial disease and has 2 investigational indications."}
{"id":"CHEMBL3183184","canonicalSmiles":"CCCCC(CC)COC(=O)C=Cc1ccc(OC)cc1","inchiKey":"YBGZDTIWKVFICR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OCTINOXATE","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Parsol"],"synonyms":["Octinoxate","Octyl methoxycinnamate"],"crossReferences":{"PubChem":["144205495","144208525","170464894"]},"count":1,"approvedIndications":["EFO_0003963"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1992 and is indicated for freckles."}
{"id":"CHEMBL3184657","canonicalSmiles":"CC1(C)[C@H](C=C(Cl)Cl)[C@H]1C(=O)OCc1c(F)c(F)cc(F)c1F","inchiKey":"DDVNRFNDOPPVQJ-HQJQHLMTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3184657","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144206228"],"drugbank":["DB15117"],"chEBI":["32253"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL319118","canonicalSmiles":"COc1ccc(OC(F)(F)F)cc1CN[C@H]1CCCN[C@H]1c1ccccc1","inchiKey":"ZIWFCOIGUNPHPM-HKUYNNGSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CP-122721","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CP-122721"],"crossReferences":{"PubChem":["144210525"],"drugbank":["DB05421"]},"childChemblIds":["CHEMBL3215877"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL32","canonicalSmiles":"COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12","inchiKey":"FABPRXSRWADJSP-MEDUHNTESA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MOXIFLOXACIN","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Avelox","Avelox i.v."],"synonyms":["Avelox","Moxifloxacin","Vigamox"],"crossReferences":{"DailyMed":["moxifloxacin%20hydrochloride"],"Wikipedia":["Moxifloxacin"],"drugbank":["DB00218"],"chEBI":["63611"]},"childChemblIds":["CHEMBL1200735","CHEMBL2326947","CHEMBL3765320"],"count":65,"approvedIndications":["EFO_0000771","EFO_1001888"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and is indicated for eye infection and bacterial disease and has 63 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3250425","canonicalSmiles":"[2H]C1([2H])C(NC(=O)N(CCCl)N=O)C([2H])([2H])C([2H])([2H])C([2H])([2H])C1([2H])[2H]","inchiKey":"GQYIWUVLTXOXAJ-YXALHFAPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3250425","maximumClinicalTrialPhase":0,"parentId":"CHEMBL514","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL32573","canonicalSmiles":"c1cc2c(c(NC3=NCCN3)c1)CCCC2","inchiKey":"QQJLHRRUATVHED-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRAMAZOLINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tramazoline"],"crossReferences":{"Wikipedia":["Tramazoline"],"drugbank":["DB13064"]},"childChemblIds":["CHEMBL2107640","CHEMBL1601957"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL328190","canonicalSmiles":"Oc1ccc2c(c1)CC[C@H](c1ccccc1)[C@@H]2c1ccc(OCCN2CCCC2)cc1","inchiKey":"GXESHMAMLJKROZ-IAPPQJPRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LASOFOXIFENE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Lasofoxifene"],"crossReferences":{"Wikipedia":["Lasofoxifene"],"drugbank":["DB06202"]},"childChemblIds":["CHEMBL2113354"],"count":2,"linkedTargets":{"rows":["ENSG00000091831","ENSG00000140009"],"count":2},"linkedDiseases":{"rows":["MONDO_0007254","EFO_0003882"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL338604","canonicalSmiles":"CCN(CC)CCNc1ccc2ncn3c4ccc(O)cc4c(=O)c1c23","inchiKey":"CUNDRHORZHFPLY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"C-1311","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-645809"],"childChemblIds":["CHEMBL3545337","CHEMBL2002951"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL3414626","canonicalSmiles":"CC(C)N(C[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)[C@H]1C[C@@H](CCc2nc3cc(C(C)(C)C)ccc3[nH]2)C1","inchiKey":"LXFOLMYKSYSZQS-LURJZOHASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PINOMETOSTAT","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EPZ-005676","EPZ-5676","Pinometostat"],"crossReferences":{"drugbank":["DB12920"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL341922","canonicalSmiles":"CC(C(=O)[O-])c1cccc(C(=O)c2ccccc2)c1.[Na+]","inchiKey":"OAPDLBHLMVYMCW-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"KETOPROFEN SODIUM","maximumClinicalTrialPhase":2,"parentId":"CHEMBL571","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Diractin","Ketoprofen sodium"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL354349","canonicalSmiles":"C[n+]1c2cc(N)ccc2cc2ccc(N)cc21.[Cl-]","inchiKey":"KKAJSJJFBSOMGS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EUFLAVINE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1184529","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acriflavinium Chloride","Euflavine"],"crossReferences":{"PubChem":["26748314","93576781"],"Wikipedia":["Acriflavinium_chloride"],"drugbank":["DB13326"],"chEBI":["383703"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3544914","canonicalSmiles":"CC(C)(CO)c1cc2cc(NC(=O)C3(c4ccc5c(c4)OC(F)(F)O5)CC3)c(F)cc2n1C[C@@H](O)CO","inchiKey":"MJUVRTYWUMPBTR-MRXNPFEDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TEZACAFTOR","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Tezacaftor","VX-661"],"crossReferences":{"drugbank":["DB11712"]},"count":1,"approvedIndications":["Orphanet_586"],"linkedTargets":{"rows":["ENSG00000001626"],"count":1},"linkedDiseases":{"rows":["Orphanet_586"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2018 and is indicated for cystic fibrosis."}
{"id":"CHEMBL3544993","drugType":"Gene","blackBoxWarning":false,"name":"AGLATIMAGENE BESADENOVEC","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Canatak","Gliatak","Oncatak","Pancatak","Prostatak","Virafir"],"synonyms":["AdV-tk","Aglatimagene besadenovec"],"count":8,"description":"Gene drug with a maximum clinical trial phase of III (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL3545281","drugType":"Small molecule","blackBoxWarning":false,"name":"AKN-028","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Akn-028"],"count":1,"linkedTargets":{"rows":["ENSG00000122025"],"count":1},"linkedDiseases":{"rows":["EFO_0000222"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545326","drugType":"Small molecule","blackBoxWarning":false,"name":"TAS-119","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tas-119"],"count":1,"linkedTargets":{"rows":["ENSG00000087586"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545335","canonicalSmiles":"Cc1cc(C(=O)Nc2cc(Nc3ccc4c(/C=C/c5ccccn5)n[nH]c4c3)ccc2F)n(C)n1","inchiKey":"JXSVVZKPEDIRTN-DHZHZOJOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AG-13958","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ag-13958"],"childChemblIds":["CHEMBL3922529"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL3545383","drugType":"Small molecule","blackBoxWarning":false,"name":"RG-7167","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Rg-7167"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545401","drugType":"Small molecule","blackBoxWarning":false,"name":"X-82","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["X-82"],"count":4,"linkedTargets":{"rows":["ENSG00000134853","ENSG00000128052","ENSG00000102755","ENSG00000037280","ENSG00000113721"],"count":5},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003860","EFO_0001365","EFO_0000228"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL356002","canonicalSmiles":"CC(=O)N/C(=C\\c1ccc(CC(=O)O)c(C=O)c1)C(=O)N[C@H]1CCCCN(Cc2ccc(-c3ccccc3)cc2)C1=O","inchiKey":"NKMPOVPTYDXGEC-MNRBYUMSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL356002","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03104"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL360216","canonicalSmiles":"O=C1NCC(=O)N2CCC[C@@H]12","inchiKey":"OWOHLURDBZHNGG-YFKPBYRVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL360216","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04541"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL365468","canonicalSmiles":"O=C(O)[C@]1(O)C=C(F)[C@@H](O)[C@H](O)C1","inchiKey":"DGZQZSSRYAJDAX-XAHCXIQSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL365468","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02786"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3670800","canonicalSmiles":"Cc1cc(C(=O)N(C)C)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)n1","inchiKey":"DWKNOLCXIFYNFV-HSZRJFAPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LAZUCIRNON","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AKST-4290","AKST4290","ALK-429","ALK-4290","ALK429","ALK4290","Akst4290","Alk-4290","Alk4290","BI144807","Lazucirnon"],"crossReferences":{"drugbank":["DB15269"]},"childChemblIds":["CHEMBL4594296"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL367588","canonicalSmiles":"Oc1ccc(-c2cc3cc(O)ccc3o2)cc1","inchiKey":"SNNNDCMXZYWCCI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL367588","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07032"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707283","canonicalSmiles":"CCOC(=O)[C@H]1O[C@H](O[C@H]2[C@@H](C(=O)OCO)O[C@H](O[C@H]3[C@@H](C(=O)OCO)O[C@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O[C@H]1O[C@H](C(=O)OCO)[C@H](O)[C@H](O)[C@H]1O","inchiKey":"MTIIUKRETHUFRF-KLJDHDAFSA-N","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"TETRAGALACTURONIC ACID HYDROXYMETHYLESTER","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tetragalacturonic acid hydroxymethylester"],"count":1,"description":"Oligosaccharide drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3707306","canonicalSmiles":"N#Cc1c(N(CC(=O)[O-])CC(=O)[O-])sc(C(=O)[O-])c1CC(=O)[O-].[Sr+2].[Sr+2]","inchiKey":"XXUZFRDUEGQHOV-UHFFFAOYSA-J","drugType":"Small molecule","blackBoxWarning":false,"name":"STRONTIUM RANELATE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL2107175","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Protelos"],"synonyms":["Ranelic acid strontium salt","Strontium ranelate"],"crossReferences":{"DrugCentral":["4714"],"drugbank":["DB09267"]},"count":1,"approvedIndications":["EFO_0004260"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for bone disease."}
{"id":"CHEMBL3707340","canonicalSmiles":"Cc1c(Br)cc(Br)c(O)c1Br","inchiKey":"QKHROXOPRBWBDD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIBROMOMETACRESOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tribromometacresol"],"crossReferences":{"drugbank":["DB13513"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL37932","canonicalSmiles":"CCOC(=O)C(C)Oc1ccc(Oc2nc3ccc(Cl)cc3o2)cc1","inchiKey":"PQKBPHSEKWERTG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FENOXAPROP-ETHYL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144211483","50113105"],"drugbank":["DB05252"],"chEBI":["5008"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL38","canonicalSmiles":"CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1","inchiKey":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TRETINOIN","yearOfFirstApproval":1971,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Acticin","Altreno","Atralin","Avita","Renova","Retin-a","Retin-a micro","Retin-a-micro","Tretin-X","Tretinoin","Vesanoid"],"synonyms":["NSC-122758","Retinoic acid","Tretinoin"],"crossReferences":{"DailyMed":["tretinoin"],"PubChem":["104171346","124882949","124882951","124882956","124882957","144204363","144209528","144210625","170465045","26746936","29214999","416403","50103969","50103970","50126361","50126362","56422209","85231340","855632","90341365"],"Wikipedia":["Retinoic_acid","Tretinoin"],"drugbank":["DB00755"],"chEBI":["15367"]},"childChemblIds":["CHEMBL2051965"],"count":35,"approvedIndications":["EFO_0000616","EFO_0003963","EFO_0003894","EFO_0000224"],"linkedTargets":{"rows":["ENSG00000131759","ENSG00000077092","ENSG00000172819"],"count":3},"linkedDiseases":{"rows":["EFO_0003869","EFO_0000756","EFO_0000464","EFO_0000231","EFO_0000565","EFO_0007160","EFO_0004251","EFO_1000044","MONDO_0019098","MONDO_0002280","EFO_0000389","MONDO_0008903","EFO_0000330","EFO_0000673","EFO_0000253","EFO_0004826","EFO_0004193","EFO_0000707","EFO_0000198","EFO_0000616","EFO_0002618","HP_0003124","EFO_0003963","HP_0001065","MONDO_0021582","MONDO_0022113","EFO_0000222","EFO_0003894","EFO_0000224","MONDO_0044881","EFO_0003060","EFO_0000621","EFO_0002496","EFO_1000760","EFO_0004268","MONDO_0100096","EFO_0000702","EFO_0000574","MONDO_0002367","EFO_0001378","MONDO_0020077"],"count":41},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1971 and has 4 approved and 31 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3833312","canonicalSmiles":"C1N2CN3CN1CN(C2)C3.O=C(O)C(O)c1ccccc1","inchiKey":"UXNFIJPHRQEWRQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHENAMINE MANDELATE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201270","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mandelamine"],"synonyms":["Hexamethylenamine mandelate","Hexamine mandelate","Hexydaline","Methenamine mandelate"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL3833329","drugType":"Antibody","blackBoxWarning":false,"name":"ERENUMAB","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aimovig"],"synonyms":["AMG 334","AMG-334","Erenumab","Erenumab-aooe"],"crossReferences":{"DailyMed":["erenumab-aooe"]},"count":3,"approvedIndications":["EFO_0003821"],"linkedTargets":{"rows":["ENSG00000064989"],"count":1},"linkedDiseases":{"rows":["EFO_1001219","EFO_0003821","EFO_0003913"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for migraine disorder and has 2 investigational indications."}
{"id":"CHEMBL386630","canonicalSmiles":"C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O","inchiKey":"MUMGGOZAMZWBJJ-DYKIIFRCSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TESTOSTERONE","yearOfFirstApproval":1972,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Androderm","Androgel","Androgel 1%","Andropatch","Axiron","Fortesta","Intrinsa","Natesto","Striant","Striant sr","Testim","Testim 1%","Testoderm","Testoderm tts","Testogel","Testopatch","Testopel","Testoral","Testosterone","Tostran","Vogelxo"],"synonyms":["Delatestryl","NSC-9700","TESTIM","Testosterone","Testosterone ciii"],"crossReferences":{"DailyMed":["testosterone"],"PubChem":["144207887","17389513","50085980","56462804"],"Wikipedia":["Testosterone"],"drugbank":["DB00624"],"chEBI":["17347"]},"count":32,"approvedIndications":["HP_0000044","EFO_1001078","MONDO_0002146","EFO_1001006","MONDO_0018555"],"linkedTargets":{"rows":["ENSG00000169083"],"count":1},"linkedDiseases":{"rows":["EFO_0002970","MONDO_0002009","EFO_0004234","EFO_1001919","Orphanet_478","MONDO_0018555","EFO_0003964","EFO_1000653","MONDO_0002146","EFO_0004714","EFO_0003144","EFO_0003884","EFO_0004215","HP_0000044","EFO_0005088","Orphanet_145","EFO_0000765","EFO_0000545","EFO_0001645","EFO_1001006","HP_0001657","EFO_0001073","EFO_0009867","EFO_0000660","HP_0030016","EFO_0001663","MONDO_0008315","EFO_0000311","EFO_0000195","GO_0007568","EFO_0003885","Orphanet_90695","EFO_1001078","MONDO_0100096","HP_0003549","EFO_0002614","EFO_0000764","MONDO_0043510","EFO_1000859","HP_0001510","EFO_0003922"],"count":41},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1972 and has 4 approved and 27 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3916717","canonicalSmiles":"Cc1cc(F)c(C(=O)Nc2cccc(-c3nncn3C(C)C)n2)cc1-n1cnc(C2CC2)c1","inchiKey":"YIDDLAAKOYYGJG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SELONSERTIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GS-4997","Gs-4997","Selonsertib"],"crossReferences":{"drugbank":["DB14916"]},"count":3,"linkedTargets":{"rows":["ENSG00000197442"],"count":1},"linkedDiseases":{"rows":["EFO_0001361","EFO_0000401","EFO_1001345"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3983283","canonicalSmiles":"C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1.O=C(O)C(O)C(O)C(=O)O","inchiKey":"NVABJQJNTPCROO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3983283","maximumClinicalTrialPhase":0,"parentId":"CHEMBL598797","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989646","canonicalSmiles":"CC(C)(C)NCC(O)c1ccc(O)c(CO)n1.Cl.Cl","inchiKey":"XIDFCZTVVCWBGN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIRBUTEROL HYDROCHLORIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL1094966","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["CP-24,314-1","Pirbuterol hydrochloride","Pyrbuterol hydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL3989690","canonicalSmiles":"CCOC[C@@H]1[C@@H](c2ccc(Cl)c(Cl)c2)C[C@@H]2CC[C@H]1N2C","inchiKey":"VCVWXKKWDOJNIT-ZOMKSWQUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TESOFENSINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NS 2330","NS-2330","Tesofensine"],"crossReferences":{"drugbank":["DB06156"]},"count":5,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL3989914","canonicalSmiles":"COCCNCc1ccc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccc(F)cc5)cc4F)c3s2)nc1","inchiKey":"YRCHYHRCBXNYNU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLESATINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Glesatinib","MG-90265","MG-90265X","MG90265","MG90265H9","MG90265X","MG90265gly","MGCD-265","MGCD265","Mgcd-265"],"crossReferences":{"drugbank":["DB06302"]},"count":2,"linkedTargets":{"rows":["ENSG00000128052","ENSG00000102755","ENSG00000037280","ENSG00000164078","ENSG00000120156","ENSG00000105976"],"count":6},"linkedDiseases":{"rows":["EFO_0003060","EFO_0000311"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3989948","canonicalSmiles":"CC#Cc1cncc(-c2ccc3c(c2)[C@@]2(N=C(C)C(N)=N2)[C@]2(CC[C@H](OC)CC2)C3)c1","inchiKey":"WKDNQONLGXOZRG-HRNNMHKYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LANABECESTAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD-3293","AZD3293","LY-3314814","LY3314814","Lanabecestat"],"crossReferences":{"drugbank":["DB14814"]},"childChemblIds":["CHEMBL3989942"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL399583","canonicalSmiles":"CCNC(=O)c1noc(-c2cc(C(C)(C)C)c(O)cc2O)c1-c1ccc(CN2CCOCC2)cc1","inchiKey":"WLYWTGDTMWWNNG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL399583","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB11881"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL40","canonicalSmiles":"CCC1(c2ccccc2)C(=O)NC(=O)NC1=O","inchiKey":"DDBREPKUVSBGFI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENOBARBITAL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Eskabarb","Luminal","Noptil","Phenobarbitone","Solfoton","Talpheno"],"synonyms":["NSC-128143","NSC-128143-","NSC-9848","Phenemal","Phenobarbital","Phenobarbital civ","Phenylethylmalonylurea"],"crossReferences":{"PubChem":["144207708","29215458","51087546"],"TG-GATEs":["4"],"Wikipedia":["Phenobarbital"],"drugbank":["DB01174"],"chEBI":["8069"]},"childChemblIds":["CHEMBL545356","CHEMBL149972"],"count":10,"approvedIndications":["EFO_0000474"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for epilepsy and has 9 investigational indications."}
{"id":"CHEMBL402744","canonicalSmiles":"O=C1C[C@@H](c2ccccc2)Oc2cc(O)ccc21","inchiKey":"SWAJPHCXKPCPQZ-AWEZNQCLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(2S)-7-Hydroxyflavanone","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(2S)-7-Hydroxyflavanone"],"crossReferences":{"drugbank":["DB04274"],"chEBI":["41888"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL409536","canonicalSmiles":"O=C(OCc1ccccc1)c1cn2c(=O)n(Cc3ccccc3)c(=O)cc2s1","inchiKey":"PLBINCOCFGQAJM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL409536","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08561"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4130229","canonicalSmiles":"Cc1ccc(C(=O)NNC(=O)c2c(C)cccc2Cl)cc1C#Cc1cnc2ccccc2c1","inchiKey":"ZQOBVMHBVWNVBG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VODOBATINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["K0706","Vodobatinib"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4204703","canonicalSmiles":"O[C@H]1CC[C@H](Nc2nc(-c3ccccc3)nc3[nH]ccc23)CC1","inchiKey":"RBZNJGHIKXAKQE-HDJSIYSDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4204703","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB12446"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4205422","canonicalSmiles":"O=C(O)CC[C@H]1CC[C@@](c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1","inchiKey":"XCGJIFAKUZNNOR-QCKZDCLWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MK-0752","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mk-0752"],"crossReferences":{"drugbank":["DB12852"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL421584","canonicalSmiles":"O=[P@]1(N(CCCl)CCCl)N[C@H](OO)CCO1","inchiKey":"VPAWVRUHMJVRHU-VGDKGRGNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL421584","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB12727"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297066","canonicalSmiles":"CCCCCCCC(=O)N[C@H](CN1CCCC1)[C@H](O)c1ccc2c(c1)OCCO2.CCCCCCCC(=O)N[C@H](CN1CCCC1)[C@H](O)c1ccc2c(c1)OCCO2.O=C(O)C(O)C(O)C(=O)O","inchiKey":"KUBARPMUNHKBIQ-ZBPSDVLKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ELIGLUSTAT TARTRATE","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2110588","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cerdelga"],"synonyms":["Eliglustat tartrate","GENZ 112638","GENZ-112638"],"crossReferences":{"DailyMed":["eliglustat%20tartrate"]},"count":1,"approvedIndications":["Orphanet_355"],"linkedTargets":{"rows":["ENSG00000148154"],"count":1},"linkedDiseases":{"rows":["Orphanet_355"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2014 and is indicated for gaucher disease."}
{"id":"CHEMBL4297109","canonicalSmiles":"CC[N+]1(C)[C@H]2CC(OC(=O)[C@H](CO)c3ccccc3)C[C@@H]1[C@H]1O[C@@H]21.[Br-]","inchiKey":"LCELQERNWLBPSY-YAYGZGPXSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"OXITROPIUM BROMIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL4297364","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Oxivent"],"synonyms":["Oxitropium bromide"],"count":1,"approvedIndications":["HP_0006536"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for airway obstruction."}
{"id":"CHEMBL4297252","canonicalSmiles":"C[C@@H]1O[C@@H](O[C@H]2[C@H](O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O)O[C@H](CO)[C@H](O)[C@@H]2O)[C@@H](O)[C@H](O)[C@@H]1O","inchiKey":"HWHQUWQCBPAQQH-BWRPKUOHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2'-FUCOSYLLACTOSE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2'-fucosyllactose"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297296","canonicalSmiles":"C/C1=C/C[C@@H](/C(C)=C/c2csc(C)n2)OC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C1","inchiKey":"XAYAKDZVINDZGB-BMVMHAJPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"KOS-1584","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Kos-1584","R1645"],"crossReferences":{"drugbank":["DB05903"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297301","canonicalSmiles":"[2H]C([2H])([2H])[N+](CCO)(C([2H])([2H])[2H])C([2H])([2H])[2H]","inchiKey":"OEYIOHPDSNJKLS-GQALSZNTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYL-D9-CHOLINE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL920","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["J2.078.736H","Methyl-d9-choline"],"crossReferences":{"drugbank":["DB12628"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297385","canonicalSmiles":"COC[C@@H]1[C@@H](c2ccc(Cl)c(Cl)c2)C[C@@H]2CC[C@H]1N2C","inchiKey":"PGYDXVBZYKQYCS-VPWBDBDCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NS-2359","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK-372,475","GSK-372475","GSK372475","Gsk372475","NS2359","Ns-2359","Ns2359"],"crossReferences":{"drugbank":["DB05805"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297441","canonicalSmiles":"CC/C=C\\C/C=C\\C/C=C\\C/C=C\\C/C=C\\C/C=C\\CCC(=O)O[C@@H](C(=O)O[C@H]1C[C@@]2(O)[C@@H](OC(=O)c3ccccc3)[C@H]3[C@](C)(C(=O)[C@H](OC(C)=O)C(=C1C)C2(C)C)[C@@H](O)C[C@H]1OC[C@]13OC(C)=O)[C@@H](NC(=O)c1ccccc1)c1ccccc1","inchiKey":"LRCZQSDQZJBHAF-PUBGEWHCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PACLITAXEL DOCOSAHEXAENOIC ACID","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dha paclitaxel","Paclitaxel docosahexaenoic acid","Taxoprexin"],"crossReferences":{"drugbank":["DB05297"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297485","canonicalSmiles":"Cc1ccncc1N1CCN(c2ccnc(Cl)c2)C1=O","inchiKey":"ZVIFCOOHWGNPHJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CFG-920","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CFG-920","CFG920","Cfg-920","Cfg920","LAE-001","LAE001","Lae001"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297593","canonicalSmiles":"CONC(=N)c1ccc(CNC(=O)[C@@H]2CCN2C(=O)[C@H](O)c2cc(Cl)cc(OC(F)F)c2)cc1","inchiKey":"XSNMGLZVFNDDPW-ZWKOTPCHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ATECEGATRAN METOXIL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD-0837","AZD0837","Atecegatran metoxil","Azd 0837","Azd0837"],"crossReferences":{"drugbank":["DB12507"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297622","canonicalSmiles":"C[C@@H]1OC(=O)N[C@@H]1C(=O)N[C@@H](Cc1cscn1)C(=O)N1CCC[C@H]1C","inchiKey":"WTXWDXWZGJGIHV-URBCHYCLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROVATIRELIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["KPS-0373","Kps-0373","Rovatirelin","S-0373"],"crossReferences":{"drugbank":["DB15338"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297781","drugType":"Unknown","blackBoxWarning":false,"name":"MCLA-158","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MCLA-158","Mcla-158"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297786","drugType":"Unknown","blackBoxWarning":false,"name":"MK-8325","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mk-8325"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297887","drugType":"Unknown","blackBoxWarning":false,"name":"GSK-2586881","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["APN-01","APN01","Apn01","GSK-2586881","Gsk-2586881","Gsk2586881"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297923","drugType":"Protein","blackBoxWarning":false,"name":"RASDEGAFUSP ALFA","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CDX-1401","Cdx-1401","Rasdegafusp alfa"],"count":3,"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL443064","canonicalSmiles":"O=C(O)CCCCc1ccccc1","inchiKey":"BYHDDXPKOZIZRV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"5-PHENYLVALERIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["5-Phenylvaleric Acid"],"crossReferences":{"drugbank":["DB04051"],"chEBI":["40131"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL44803","canonicalSmiles":"Nc1nc(O)c2nn(-c3cccc(C(=O)NCc4cc(Cl)cc(Cl)c4)c3)nc2n1","inchiKey":"JMQTXEWNXSPEKX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL44803","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03571"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL451635","canonicalSmiles":"O/N=C/c1cc[n+](COC[n+]2ccc(/C=N/O)cc2)cc1","inchiKey":"HIGRLDNHDGYWQJ-UHFFFAOYSA-P","drugType":"Small molecule","blackBoxWarning":false,"name":"OBIDOXIME","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Obidoxime"],"crossReferences":{"drugbank":["DB13750"]},"childChemblIds":["CHEMBL590824","CHEMBL291233"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4523032","canonicalSmiles":"Cl.Nc1ncccc1-c1nc2ccc(-c3ccccc3)nc2n1-c1ccc(C2(N)CCC2)cc1","inchiKey":"DRHSWSSVIKDJME-UHFFFAOYSA-N","drugType":"unknown","blackBoxWarning":false,"name":"CHEMBL4523032","maximumClinicalTrialPhase":0,"parentId":"CHEMBL4297188","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Unknown drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL458966","canonicalSmiles":"N#Cc1ccc(COc2ccc3cc(S(=O)(=O)N[C@H](CCC(=O)O)C(=O)O)ccc3c2)cc1","inchiKey":"PUHRQSFXADUGJW-OAQYLSRUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL458966","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08108"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594365","drugType":"Unknown","blackBoxWarning":false,"name":"REN-001","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HPP-593","HPP593","Hpp593","REN-001","Ren-001"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594410","canonicalSmiles":"COc1ccc(S(=O)(=O)NCc2cc(CN3CCCC3)c(O)c(CN3CCCC3)c2)cc1.O=S(=O)(O)O","inchiKey":"BQCSIJGCWZAHPG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULCARDINE SULFATE","maximumClinicalTrialPhase":1,"parentId":"CHEMBL3638051","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HBI-3000","Hbi-3000","Sulcardine sulfate"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594618","drugType":"Gene","blackBoxWarning":false,"name":"BREXUCABTAGENE AUTOLEUCEL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Brexucabtagene autoleucel","KTE-X19"],"description":"Gene drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL465183","canonicalSmiles":"CCCCC/C=C\\C/C=C\\C/C=C\\CCCCCCC(=O)O","inchiKey":"HOBAELRKJCKHQD-QNEBEIHSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIHOMO-GAMMA-LINOLENIC ACID","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["20:3(N-6)","Cis-8,11,14-Eicosatrienoicacid","DS-107G","DS107G","Dihomo-gamma-linolenic acid","Diroleuton","RO 12-1989"],"crossReferences":{"PubChem":["26754937","26754938"],"drugbank":["DB00154"],"chEBI":["53486"]},"childChemblIds":["CHEMBL3274189"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL473119","canonicalSmiles":"Cc1n[nH]c2ccc(F)c(Oc3cc(C#N)cc(C#N)c3)c12","inchiKey":"JYAHFMKZJRVTDT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL473119","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07935"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL474857","canonicalSmiles":"O=C(N/N=C/c1cc(Br)c(O)c(Br)c1O)c1ccc(Br)cc1","inchiKey":"HKNUDJDAVYPTGD-NGYBGAFCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL474857","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07098"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL477874","canonicalSmiles":"FC(F)(F)COCC(F)(F)F","inchiKey":"KGPPDNUWZNWPSI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUROTHYL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Indoklon"],"synonyms":["Flurothyl","Flurotyl","Hexafluorodiethyl ether","SK&F 6539"],"crossReferences":{"drugbank":["DB08969"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL499915","canonicalSmiles":"CC1(C)[C@@H](OC(=O)CCC(=O)O)CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@@](C)(C(=O)O)CC[C@]3(C)CC[C@]21C","inchiKey":"OBZHEBDUNPOCJG-WBXJDKIVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBENOXOLONE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Carbenoxolone"],"crossReferences":{"Wikipedia":["Carbenoxolone"],"drugbank":["DB02329"]},"childChemblIds":["CHEMBL1697717"],"count":2,"approvedIndications":["EFO_0003948","HP_0004398"],"linkedTargets":{"rows":["ENSG00000176387","ENSG00000117594"],"count":2},"linkedDiseases":{"rows":["EFO_0003948","HP_0004398"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for gastroesophageal reflux disease and peptic ulcer."}
{"id":"CHEMBL503090","canonicalSmiles":"O=C(Cc1ccc(F)cc1)NC(=O)Nc1ccc(Oc2ccnc3[nH]ccc23)c(F)c1","inchiKey":"BMPOCDJEXAXXEZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL503090","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06997"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL51969","canonicalSmiles":"COC(=O)[C@@H](N)Cc1ccccc1","inchiKey":"VSDUZFOSJDMAFZ-VIFPVBQESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENYLALANINE METHYL ESTER","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(S)-Phenylalanine Methylester","L-Phenylalanine Methyl Ester"],"crossReferences":{"drugbank":["DB06838"],"chEBI":["49339"]},"childChemblIds":["CHEMBL1221959"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL52270","canonicalSmiles":"CC(=O)N[C@@H]1[C@@H](N)C=C(C(=O)O)O[C@H]1[C@H](O)[C@H](O)CO","inchiKey":"NKENBBIXEGPQLS-UFGQHTETSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"4-amino-4-deoxy-Neu5Ac2en","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-amino-4-deoxy-Neu5Ac2en"],"crossReferences":{"drugbank":["DB03321"]},"childChemblIds":["CHEMBL3330706"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL539666","canonicalSmiles":"Clc1ccc2c(N3CCN(CCCN4CCN(c5ccnc6cc(Cl)ccc56)CC4)CC3)ccnc2c1.O=P(O)(O)O","inchiKey":"KATNPMSTHHZOTK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIPERAQUINE PHOSPHATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL303933","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Piperaquine phosphate"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL549906","canonicalSmiles":"O=C(O)Cc1ccc(-c2c[nH]c3ncc(-c4ccc5ccccc5c4)cc23)cc1","inchiKey":"SWXKLXXVFMYMDP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL549906","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07837"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL550781","canonicalSmiles":"CCCCCN(CCCOC)C(=O)[C@@H](CCC(=O)O)NC(=O)c1ccc(Cl)c(Cl)c1","inchiKey":"QNQZBKQEIFTHFZ-GOSISDBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXLOXIGLUMIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CR-2017","Dexloxiglumide","Loxiglumide (r)-form"],"crossReferences":{"Wikipedia":["Dexloxiglumide"],"drugbank":["DB04856"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL55400","canonicalSmiles":"Nc1ccc2cc3ccc(N)cc3nc2c1","inchiKey":"WDVSHHCDHLJJJR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROFLAVINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Proflavine"],"crossReferences":{"PubChem":["29218003"],"Wikipedia":["Proflavine"],"drugbank":["DB01123"],"chEBI":["8452"]},"childChemblIds":["CHEMBL465704","CHEMBL1964546","CHEMBL606782","CHEMBL3186253","CHEMBL2105299"],"count":4,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL562317","canonicalSmiles":"c1ccc2nc(COc3ccc(-c4n[nH]cc4Cc4ccncc4)cc3)ccc2c1","inchiKey":"RQDDHVVAAJVVKM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL562317","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08384"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL567204","canonicalSmiles":"Cc1cc(C)cc(Oc2c(CSCc3ccco3)c(C)[nH]c(=O)c2I)c1","inchiKey":"YZLKVEDFWLGNQP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL567204","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08457"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL573677","canonicalSmiles":"C[C@H](CCOc1cccc(CC(=O)O)c1)N(Cc1cccc(C(F)(F)F)c1Cl)CC(c1ccccc1)c1ccccc1","inchiKey":"ZLJZDYOBXVOTSA-XMMPIXPASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RGX-104","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["RGX-104","Rgx-104","SB-742881"],"count":1,"linkedTargets":{"rows":["ENSG00000131408","ENSG00000025434"],"count":2},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL58547","canonicalSmiles":"CC(C)(N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](Cc1ccc2ccccc2c1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(N)=O","inchiKey":"NEHWBYHLYZGBNO-BVEPWEIPSA-N","drugType":"Protein","blackBoxWarning":false,"name":"IPAMORELIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ipamorelin","NNC 26-0161","NNC-26-0161","NNC-260161"],"crossReferences":{"PubChem":["50112591"],"drugbank":["DB12370"]},"description":"Protein drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL58752","canonicalSmiles":"O=[N+]([O-])c1nccn1CC(O)CN1CCCCC1","inchiKey":"WVWOOAYQYLJEFD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIMONIDAZOLE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-380540","PD 126675","PD-126675","Pimonidazole","RO 03-8799","RO-03-8799","RO-038799"],"crossReferences":{"PubChem":["470365"],"drugbank":["DB12485"]},"count":4,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL58832","canonicalSmiles":"NC(=O)C[C@H](N)C(=O)O","inchiKey":"DCXYFEDJOCDNAF-REOHCLBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ASPARAGINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Asparagine","L-asparagine"],"crossReferences":{"Wikipedia":["Asparagine"],"drugbank":["DB00174"],"chEBI":["17196"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL60851","canonicalSmiles":"O=C(O)CBr","inchiKey":"KDPAWGWELVVRCH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BROMOACETIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Bromoacetic Acid","Bromo-Acetic Acid","Bromoacetic Acid"],"crossReferences":{"PubChem":["144207855","17389676"],"Wikipedia":["Bromoacetic_acid"],"drugbank":["DB02198"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL611940","canonicalSmiles":"O=C1N[C@@]2(O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C(=O)N1O","inchiKey":"IHDZZZHACPJCFJ-WWHASAIZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL611940","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02447"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL6269","canonicalSmiles":"Cc1nccn1CCCCc1ccc(CC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)NCCC2CCCCC2)cc1","inchiKey":"WHLPIOSHBKQGHA-KYJUHHDHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SC-58272","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SC-58272"],"crossReferences":{"drugbank":["DB02477"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL640","canonicalSmiles":"CCN(CC)CCNC(=O)c1ccc(N)cc1","inchiKey":"REQCZEXYDRLIBE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PROCAINAMIDE","yearOfFirstApproval":1950,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["NSC-27461","Procainamide","Procan","Procanbid","Procapan","Pronestyl","Pronestyl-SR"],"crossReferences":{"DailyMed":["procainamide%20hydrochloride"],"PubChem":["11111690","11111691","144203797","170464952","26751611","90340905"],"Wikipedia":["Procainamide"],"drugbank":["DB01035"],"chEBI":["8428"]},"childChemblIds":["CHEMBL605"],"count":6,"approvedIndications":["EFO_0004269"],"linkedTargets":{"rows":["ENSG00000196876","ENSG00000185313","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000136531","ENSG00000007314","ENSG00000153253"],"count":10},"linkedDiseases":{"rows":["EFO_0000275","EFO_0004269","EFO_0004287","EFO_0003144","EFO_0004278","EFO_0000612"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1950 and is indicated for cardiac arrhythmia and has 5 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL645","canonicalSmiles":"CC(C)NCC(O)COc1ccc(COCCOC(C)C)cc1","inchiKey":"VHYCDWMUTMEGQY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BISOPROLOL","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Bisoprolol","CL 297,939","CL-297939","EMD 33 512","EMD-33-512","Zebeta","Ziac"],"crossReferences":{"DailyMed":["bisoprolol%20fumarate"],"PubChem":["174007419","26751965","29215032","50104637","90341096"],"Wikipedia":["Bisoprolol"],"drugbank":["DB00612"],"chEBI":["3127"]},"childChemblIds":["CHEMBL1200708","CHEMBL1472989"],"count":5,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000043591"],"count":1},"linkedDiseases":{"rows":["Orphanet_275766","EFO_0000275","EFO_0001645","EFO_0005252","MONDO_0007254","EFO_0000373","EFO_0000319","EFO_0000266","EFO_0000537","EFO_0003913","Orphanet_98896","MP_0001914","EFO_0008585","Orphanet_79292","EFO_0003144","EFO_0008583","EFO_0000341","EFO_0008586"],"count":18},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1992 and is indicated for cardiovascular disease and has 4 investigational indications."}
{"id":"CHEMBL65730","canonicalSmiles":"C=CCN(C)C/C=C/COc1cc2c(cc1F)c(-c1ccc(Br)cc1)nn2C","inchiKey":"YDWPQZUWZDRRSE-AATRIKPKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL65730","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02139"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL734","canonicalSmiles":"CC(=O)NO","inchiKey":"RRUDCFGSUDOHDG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACETOHYDROXAMIC ACID","yearOfFirstApproval":1983,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lithostat"],"synonyms":["Acetohydroxamic acid","NSC-176136"],"crossReferences":{"DailyMed":["acetohydroxamic%20acid"],"PubChem":["144204853","170465439","26747835"],"Wikipedia":["Acetohydroxamic_acid"],"drugbank":["DB00551"],"chEBI":["27777"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1983 and has 3 investigational indications."}
{"id":"CHEMBL75435","canonicalSmiles":"C[C@H](C(=O)O)c1cccc(C(=O)c2ccccc2)c1","inchiKey":"DKYWVDODHFEZIM-NSHDSACASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXKETOPROFEN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Keral"],"synonyms":["Dexketoprofen"],"crossReferences":{"PubChem":["26754382","26754383","56320640"],"drugbank":["DB09214"],"chEBI":["76128"]},"count":4,"approvedIndications":["HP_0002829","HP_0003326","EFO_0005755"],"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","EFO_1001412","HP_0003326","EFO_1001139","EFO_0005296","HP_0002829","EFO_0003821","EFO_0000677","HP_0100607","HP_0003419","MONDO_0002258","EFO_0003843","EFO_0005755"],"count":13},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 3 approved and 1 investigational indication."}
{"id":"CHEMBL91649","canonicalSmiles":"O=C(O)[C@H](Cc1c[nH]c2ccccc12)NS(=O)(=O)c1ccc(N2CCC(c3ccccc3)CC2)cc1","inchiKey":"ULOTXPTWJAUGGE-MHZLTWQESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL91649","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02449"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL922","canonicalSmiles":"CC(C)(C)C(=O)OCOP(=O)(COCCn1cnc2c(N)ncnc21)OCOC(=O)C(C)(C)C","inchiKey":"WOZSCQDILHKSGG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ADEFOVIR DIPIVOXIL","yearOfFirstApproval":2002,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Adefovir dipivoxil","Hepsera"],"synonyms":["Adefovir di(pivaloyloxymethyl) ester","Adefovir dipivoxil","Adefovir pivoxil","GS-0840","Hepsera"],"crossReferences":{"DailyMed":["adefovir%20dipivoxil"],"PubChem":["144205796","170464742","174007317","26758046"],"drugbank":["DB00718"]},"childChemblIds":["CHEMBL537884"],"count":5,"approvedIndications":["EFO_0004197","EFO_0000763","EFO_0004239"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2002 and has 3 approved and 2 investigational indications. This drug has a black box warning from the FDA."}
